Log In
Print
BCIQ
Print
Print this Print this
 

Ergidina, SAND 5

  Manage Alerts
Collapse Summary General Information
Company Adienne Pharma & Biotech
DescriptionRecombinant human minibody against complement component C5 (C5) fused with RGD-motif
Molecular Target Complement 5 (C5)
Mechanism of ActionComplement inhibitor
Latest Stage of DevelopmentPreclinical
IndicationIschemia / reperfusion injury
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today